SEC Form 4 · accession 0001209191-19-005182
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Parini
Officer — EVP, CL&AO
Period of report
Jan 22, 2019
Accepted (ET)
Jan 24, 2019 · 4:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 22, 2019 | M | 3,668 | $155.57 | A | 43,277 | D | |
| Common Stock | Jan 22, 2019 | S | 3,668 | $195.00 | D | 39,609 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $155.57 | Jan 22, 2019 | M | 3,668 | D | — | Feb 5, 2028 | Common Stock | 3,668 | 15,898 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- F2The option vests in 16 quarterly installments from 02/06/2018.